IXICO to Present at SCA & ARCA Global Conference

IXICO plc announces that Dr Robin Wolz, Senior Vice President of Science & Innovation at IXICO, will present on the industry panel at the virtual SCA & ARCA Global Conference, taking place on 19-21 October 2020.

The SCA & ARCA Global Conference brings together two initiatives that focus on ataxia, which is the loss of coordination of voluntary muscle movements. This platform allows for  academic and industry leaders, physicians and companies working in the space to collaborate on developing future treatments for patients.

Autosomal-recessive cerebellar ataxias (ARCA) are a heterogeneous group of rare degenerative and metabolic genetic diseases recessively inherited and spinocerebellar ataxias (SCAs) are a group of autosomal dominantly inherited progressive ataxia disorders. The clinical manifestations of hereditary ataxias are poor coordination of movement and unsteady gait.

Dr Robin Wolz will be presenting on the industry panel on 20 October at 16.20 (BST). The talk is titled: "Challenges and opportunities in the deployment of volumetric MRI in SCA clinical trials." Additionally, IXICO are supporting the conference as an official partner of SCA & ARCA Global 2020.

Dr Robin Wolz, Senior Vice President, Science & Innovation at IXICO commented: "Ataxia conditions continue to be a focus for IXICO in its efforts to provide pioneering technologies to support the advancement of effective treatments for rare neurological diseases. Our research in imaging analytics will provide an insight into the best methods for monitoring both the progression of the disease as well as the potential effect of interventional treatments."

Additional info can be found on the conference website: http://ataxia-global-initiatives.net/sca-global/conferences/sca-global-2020/ 


Date: 19/10/2020